Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1618
This examiner grants 52% of resolved cases
Melissa Jean Perreira is an examiner in Art Unit 1618 within Tech Center 1600. The examiner has 836 resolved cases and an allowance rate of 52.0 percent. This rate indicates a balanced outcome for applications in this unit. The examiner's record provides a basis for understanding prosecution trends in this unit.
The interview lift is 25.8 percent, which indicates that conducting an interview significantly increases the probability of allowance compared to the baseline rate of 52.0 percent. This is a strong recommendation for practitioners to engage with the examiner directly. For applications that reach allowance, the median time to allowance is 1375 days. This pendency figure provides a timeline for the expected duration of prosecution.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16400922 | Pharmaceutical Compositions of Near IR Closed Chain, Sulfo-Cyanine Dyes | Final Rejection | Intuitive Surgical Operations, Inc. |
| 18080346 | METHODS AND MATERIALS FOR TREATING HYPOCAPNIA | Final Rejection | Mayo Foundation for Medical Education and Research |
| 19394360 | NEUROTENSIN RECEPTOR 1 (NTSR1) TARGETED THERAPEUTICS AND USES THEREOF | Non-Final OA | Radionetics Oncology, Inc. |
| 17040967 | METHODS AND ASSAYS FOR MODULATING GENE TRANSCRIPTION BY MODULATING CONDENSATES | Final Rejection | Massachusetts Institute of Technology |
| 18990863 | IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA) | Final Rejection | The Johns Hopkins University |
| 18052804 | PSMA-TARGETING COMPOUNDS AND USES THEREOF | Non-Final OA | The Johns Hopkins University |
| 19240908 | METHOD OF TREATING PROSTATE CANCER | Non-Final OA | Novartis AG |
| 17542358 | PAPD5 AND PAPD7 INHIBITORS FOR TREATING A HEPATITIS B INFECTION | Non-Final OA | HOFFMANN-LA ROCHE INC. |
| 18969629 | Stable Soft Chews, and Methods to Produce Same | Non-Final OA | Florida Research Group, LLC |
| 17866034 | PSMA LIGANDS FOR IMAGING AND ENDORADIOTHERAPY | Non-Final OA | Technische Universitat Munchen |
| 17477419 | COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY | Final Rejection | Rakuten Medical, Inc. |
| 17469804 | COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY | Non-Final OA | Rakuten Medical, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy